PRMT5 and myeloproliferative neoplasm: Abnormalities in DNA methylation are recognized in MPN, with JAK2 mutated patients showing impaired methylation of histone subsets, due to higher affinity binding of protein arginine methyltransferase 5 (PRMT5), resulting in promotion of myeloproliferation [37] (Will be discussed in the new targeting therapy).